CompanyDrug

Merck’s Keytruda Gains Expanded Approval for First-Line Melanoma Treatment in China

CompanyDrug

iTeos Therapeutics and GSK’s Belrestotug/Dostarlimab Combo Shows Promising Results in NSCLC

CompanyDrug

Merck and Daiichi Sankyo’s HER3-DXd ADC Patritumab Deruxtecan Passes Phase 3 Trial After FDA Rejection

CompanyDrug

Kangfang Biotech Presents Groundbreaking mCRC Treatment Data at ESMO Congress

CompanyDrug

Kangfang Biotech’s Yivoxi Shows Promising Results in First-Line TNBC Treatment at ESMO Congress

CompanyDrug

Kangfang Biotech’s Yivoxi Shows Promising Results in Treating R/M HNSCC at ESMO Congress

CompanyDrug

Shanghai Pharmaceuticals’ Dual-Targeting CAR-T Therapy Advances with IND Re-Acceptance

Company

Walsun Biotech Achieves Top ESG Rating, Underscores Commitment to Sustainability

CompanyDrug

Novartis’ Cemiplimab Approved in China for Moderate-to-Severe Atopic Dermatitis

CompanyHospital

Innovent Biologics Launches Phase I Clinical Trial for IBR822 Cell Injection Solution in Solid Tumors

CompanyDrug

Johnson & Johnson’s Tremfya Gains FDA Approval for Ulcerative Colitis Treatment

CompanyDeals

Sanofi Secures Global Rights to Radioligand Therapy AlphaMexi in Deal with RadioMedix and Orano Med